News Focus
News Focus
Followers 10
Posts 1420
Boards Moderated 0
Alias Born 08/08/2015

Re: sts66 post# 314166

Thursday, 12/10/2020 6:53:47 AM

Thursday, December 10, 2020 6:53:47 AM

Post# of 447652
I was invested in a company (SPPI) years ago that had an approved drug (Fusilev) that went generic. Several times the generic was put on a warning list due to limited supply and backlog. Not sure but I think Teva was one of the suppliers. Long story short the SPPI product could cover those shortages and the SP reflected that in a 50% uptick. And here we were only talking around 40 mill per quarter.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News